Submit Article
Legal Analysis. Regulatory Intelligence. Jurisprudence.
Search articles, case studies, legal topics...
Singapore

Asia-Euro Capital SPV I LLP v Regulus Advisors Pte Ltd and others [2024] SGHC 279

The court dismissed the plaintiff's claims for misrepresentation and unlawful means conspiracy, finding that the alleged representations were not made and that the plaintiff failed to prove reliance or loss.

300 wpm
0%
Chunk
Theme
Font

Case Details

  • Citation: [2024] SGHC 279
  • Court: General Division of the High Court of the Republic of Singapore
  • Decision Date: 30 October 2024
  • Coram: Mohamed Faizal JC
  • Case Number: Suit No 862 of 2021
  • Hearing Date(s): 24–27 June, 19 August 2024
  • Claimants / Plaintiffs: Asia-Euro Capital SPV I LLP
  • Respondent / Defendant: Regulus Advisors Pte Ltd (1st Defendant); Amit Bagri (2nd Defendant); Don Lim Jung Chiat (3rd Defendant)
  • Counsel for Claimants: [None recorded in extracted metadata]
  • Counsel for Respondent: [None recorded in extracted metadata]
  • Practice Areas: Tort; Conspiracy; Unlawful means conspiracy; Misrepresentation

Summary

The judgment in Asia-Euro Capital SPV I LLP v Regulus Advisors Pte Ltd and others [2024] SGHC 279 provides a definitive examination of the evidentiary hurdles faced by sophisticated commercial parties seeking to enforce alleged oral guarantees that contradict or supplement written investment documentation. The dispute arose from a US$550,000 investment by the plaintiff, a Singapore-registered limited liability partnership, into shares of AVIVO, a healthcare provider. The plaintiff alleged that it was induced to enter into this transaction by four specific oral representations made by the 2nd defendant, Amit Bagri, acting on behalf of the 1st defendant, Regulus Advisors Pte Ltd (formerly Al Masah Capital (Asia) Pte Ltd). These representations purportedly guaranteed a 9% annual dividend, a specific calculation methodology based on an "original" share price of US$1.00, the personal ownership of the shares by a prominent principal, and a commitment by the defendants not to divest their own holdings.

The High Court dismissed the suit in its entirety, finding that the plaintiff failed to establish, on a balance of probabilities, that the alleged oral representations were ever made. Mohamed Faizal JC’s reasoning centered on the "inherent improbability" of such significant commercial guarantees being extended orally without any contemporaneous documentary record. The court observed that the plaintiff, as a sophisticated investment vehicle managed by an experienced professional, Mr. Choo, would have been expected to insist on written confirmation of any "guaranteed" returns, especially when the formal Information Memorandum and teasers utilized language of "targets" and "projections" rather than certainties. The judgment reinforces the principle that in commercial litigation, the court will prioritize the objective documentary matrix over subjective, inconsistent oral testimony delivered years after the events in question.

Doctrinally, the case clarifies the application of the Misrepresentation Act 1967 and the tort of deceit in the context of private equity investments. The court held that even if the representations had been made, the plaintiff failed to prove reliance or actionable loss. Specifically, the plaintiff could not demonstrate that the value of the AVIVO shares at the time of acquisition was less than the price paid, rendering the claim for damages unsustainable. Furthermore, the failure of the primary misrepresentation claims led to the collapse of the derivative claim for unlawful means conspiracy. The court’s analysis of the "sophisticated investor" standard serves as a critical warning to practitioners: the more experienced the investor, the higher the court's expectation that they will protect their interests through formal contractual terms rather than relying on alleged side-bar oral assurances.

Ultimately, the decision underscores the finality and primacy of written subscription agreements. It highlights that silence or the failure to correct a third party's misunderstanding does not necessarily constitute an actionable misrepresentation unless a specific duty to speak exists. By dismissing the claims against all three defendants, the court affirmed that the risks inherent in private equity—including the failure to meet "target" dividends—cannot be converted into tortious liability through the retrospective characterization of marketing projections as oral guarantees. This judgment stands as a significant precedent for the defense of fund managers and investment advisors against claims of "broken promises" that lack a foundation in the executed legal instruments of the transaction.

Timeline of Events

  1. 13 March 2015: Initial operational dates and internal records regarding the Al Masah Capital group's investment strategies and the promotion of private equity opportunities.
  2. 19 April 2016: Communications regarding the investment landscape in the UAE healthcare and education sectors, involving the 1st defendant.
  3. 26 July 2016: Dissemination of initial marketing materials and teasers to potential investors regarding AVIVO and Al Najah Education Limited (ANEL).
  4. 16 August 2016: Further promotional activities by the defendants targeting sophisticated investors for the AVIVO share offering.
  5. 16 September 2014: (Contextual date) Early records of the share issuance and pricing structure of the underlying assets.
  6. 7 October 2016: Formal investment teasers for AVIVO shares are sent to the plaintiff, outlining "target" dividend yields.
  7. 10 October 2016: A pivotal meeting occurs between Mr. Choo (representing the plaintiff) and the 2nd defendant, during which the plaintiff alleges the first set of oral representations were made.
  8. 20 October 2016: Continued correspondence between the parties regarding the US$550,000 subscription proposal.
  9. 24 October 2016: Discussions regarding the share price (approx. US$2.80) and the mechanics of the dividend payments.
  10. 27 October 2016: An internal email is sent by the 2nd defendant, which the plaintiff later relies upon as evidence of the alleged representations.
  11. 28 October 2016: The plaintiff moves toward formalizing the subscription for US$550,000 worth of AVIVO shares.
  12. 29 October 2016: Commencement of the formal subscription process.
  13. 1 November 2016: Execution of the subscription documents by the plaintiff and the transfer of the US$550,000 investment funds.
  14. 10 November 2016: Administrative processing of the share subscription by the 1st defendant.
  15. 16 November 2016: Finalization of the investment records within the Regulus (formerly Al Masah) systems.
  16. 22 November 2016: Documentation of share ownership and the processing of the plaintiff's entry into the share register.
  17. 23 November 2016: Final administrative steps in the initial investment phase.
  18. 28 November 2016: Conclusion of the primary subscription period for the plaintiff's tranche of shares.
  19. 29 November 2016: Full processing and confirmation of the US$550,000 investment.
  20. 30 November 2016: Post-investment administrative actions commence.
  21. 1 December 2016: Formal issuance of share certificates or confirmation of ownership to the plaintiff.
  22. 5 December 2016: Final 2016 records regarding the transaction are settled.
  23. 12 December 2016: Final settlement of the subscription funds.
  24. 13 December 2016: Conclusion of the immediate post-investment administrative phase.
  25. 15 December 2016: The plaintiff begins monitoring the performance of the AVIVO investment.
  26. 19 December 2016: Initial reports on dividend performance are reviewed by the plaintiff.
  27. 5 January 2017: Continued tracking of the investment's progress and dividend accruals.
  28. 10 January 2017: Records relating to a dividend payment or update are issued to the plaintiff.
  29. 23 January 2017: Further updates on the AVIVO investment performance.
  30. 27 February 2017: The plaintiff identifies a discrepancy between the 7% dividend paid and the alleged 9% guarantee.
  31. 12 March 2017: The plaintiff initiates an internal investigation into the representations made during the October 2016 meetings.
  32. 16 March 2017: Formal inquiry sent by the plaintiff to the defendants regarding the dividend shortfall and calculation methodology.
  33. 21 August 2017: Exchange of letters between legal counsel for the parties.
  34. 14 September 2017: Continued legal correspondence regarding the alleged misrepresentations.
  35. 5 November 2017: The plaintiff seeks clarification on the "original share price" calculation.
  36. 27 November 2017: Disputes arise regarding the ownership of the shares sold to the plaintiff (the "skin in the game" issue).
  37. 30 November 2017: The defendants formally deny all allegations of oral guarantees.
  38. 5 December 2017: The plaintiff demands compensation for the alleged losses.
  39. 12 December 2017: Final pre-litigation correspondence between the parties.
  40. 13 December 2017: The plaintiff begins preparing the legal claim.
  41. 7 January 2018: Internal review of the evidence by the plaintiff's legal team.
  42. 10 January 2018: Further review of the subscription documents and Information Memorandum.
  43. 15 January 2018: Finalization of the draft Statement of Claim.
  44. 21 February 2018: Exchange of formal legal notices.
  45. 7 March 2018: The defendants maintain their position that no oral representations were made.
  46. 19 April 2018: Significant date in the pre-trial phase.
  47. 16 August 2018: Continued procedural developments.
  48. 25 September 2019: Further procedural milestones.
  49. 16 January 2020: Pre-trial conferences continue.
  50. 29 July 2020: Procedural orders issued by the court.
  51. 27 October 2020: Finalization of the witness lists.
  52. 4 November 2020: Exchange of Affidavits of Evidence-in-Chief (AEICs).
  53. 30 July 2021: Further procedural updates.
  54. 31 July 2021: Final preparations for the writ filing.
  55. 20 October 2021: The plaintiff files the Writ of Summons (Suit No 862 of 2021).
  56. 6 February 2023: Trial dates scheduled.
  57. 25 April 2023: Pre-trial directions issued.
  58. 30 August 2023: Final exchange of documents.
  59. 13 September 2023: Final pre-trial conference.
  60. 16 February 2024: Opening statements filed.
  61. 19 June 2024: Final trial preparations.
  62. 24–27 June, 19 August 2024: Substantive hearing of the trial before Mohamed Faizal JC.
  63. 22 July 2024: Closing submissions filed.
  64. 5 August 2024: Reply submissions filed.
  65. 30 October 2024: The High Court delivers its judgment, dismissing the suit in its entirety.

What Were the Facts of This Case?

The plaintiff, Asia-Euro Capital SPV I LLP, is a Singapore-registered limited liability partnership established as a special purpose vehicle for investment. It was managed by Mr. Choo, a professional with extensive experience in the financial and investment sectors. The 1st defendant, Regulus Advisors Pte Ltd (formerly known as Al Masah Capital (Asia) Pte Ltd), was a registered fund management company in Singapore. The 2nd defendant, Amit Bagri, served as a director and key executive of the 1st defendant, while the 3rd defendant, Don Lim Jung Chiat, was also associated with the firm's operations. The core of the dispute involved the plaintiff's subscription to US$550,000 worth of shares in AVIVO, a healthcare provider operating in the Middle East, which was part of a portfolio of private equity assets managed or promoted by the Al Masah Capital group.

In late 2016, the defendants promoted the AVIVO investment opportunity to the plaintiff. The transaction was structured as a private placement where the plaintiff would purchase shares at a price of approximately US$2.80 per share. The plaintiff alleged that during meetings on 10 October 2016 and 24 October 2016, as well as through subsequent communications, Amit Bagri made four specific oral representations (the "Alleged Representations") that induced the plaintiff to invest. These representations were:

  • The Dividend Rate Representation: That AVIVO would pay a guaranteed annual dividend of 9%.
  • The Calculation Methodology Representation: That this 9% dividend would be calculated based on the "original share price" of US$1.00 (the price at which the shares were initially issued), rather than the US$2.80 purchase price paid by the plaintiff.
  • The Ownership Representation: That the shares being sold to the plaintiff were personally owned by Mr. Shailesh Dash, the founder of Al Masah Capital, thereby demonstrating his personal commitment to the venture.
  • The Non-Disposal Representation: That the defendants and their principals had no intention of disposing of their own holdings in AVIVO in the near future.

The plaintiff’s case rested on the assertion that these representations were false. Specifically, the plaintiff discovered that the actual dividend paid was 7% per annum, and it was not calculated in the manner purportedly promised. Furthermore, the plaintiff alleged that the shares were not owned by Mr. Dash personally but by an entity controlled by him, and that the defendants had in fact disposed of certain shares. The plaintiff claimed that these misrepresentations were made fraudulently (in deceit) or, in the alternative, negligently under the Misrepresentation Act 1967. The plaintiff sought damages representing the difference between the "guaranteed" 9% return and the actual 7% return, as well as the loss of the principal investment.

The defendants denied making any such oral guarantees. They contended that all discussions regarding dividends were clearly framed as "targets" or "projections," consistent with the language used in the Information Memorandum and the investment teasers provided to the plaintiff. They argued that the plaintiff, as a sophisticated investor, understood the inherent risks of private equity and knew that dividends in such ventures are never "guaranteed." The defendants also pointed to the absence of any written record of these alleged guarantees in the subscription agreement or any contemporaneous emails. They maintained that the plaintiff’s version of the meetings was a retrospective attempt to recoup losses from an investment that did not perform as highly as hoped. The 3rd defendant’s involvement was also contested, with the defendants arguing he had no role in the alleged misrepresentations.

The trial involved extensive cross-examination of Mr. Choo and Mr. Bagri. The court scrutinized the consistency of their testimonies against the documentary evidence, including internal emails and the formal subscription documents. A key piece of evidence was an email dated 27 October 2016 from Mr. Bagri to Mr. Choo, which the plaintiff claimed corroborated the 9% guarantee. The defendants, however, argued that this email merely reflected the "target" yield discussed in the marketing materials. The court also considered the plaintiff's failure to call other potential witnesses who were present at the meetings, leading to arguments regarding the drawing of adverse inferences under the Evidence Act 1893.

The primary legal issue was whether the Alleged Representations were actually made by the 2nd defendant to the plaintiff. This was a threshold question of fact that required the court to weigh the conflicting oral testimonies of Mr. Choo and Mr. Bagri. The court had to determine if the plaintiff had met the burden of proof on a balance of probabilities, particularly in light of the "inherent improbability" of oral guarantees in a multi-million dollar commercial context. This issue was framed by the principles in [2014] SGHC 8, which emphasize the importance of contemporaneous documents over oral evidence.

The second issue concerned the elements of the tort of deceit and negligent misrepresentation under s 2(1) of the Misrepresentation Act 1967. If the representations were made, the court had to decide if they were false, if the defendants knew they were false (for deceit), or if the defendants had no reasonable grounds to believe they were true (for negligent misrepresentation). This involved an analysis of the "target" vs "guarantee" distinction and whether the defendants' silence on certain matters (like the exact ownership of the shares) constituted an actionable misrepresentation by omission, citing [2021] SGHC 193.

The third issue was reliance and inducement. The court had to determine whether the plaintiff actually relied on the Alleged Representations when deciding to invest US$550,000. This required an assessment of the plaintiff's sophistication and whether it was reasonable for an experienced investor like Mr. Choo to rely on oral statements that were not reflected in the formal subscription documents. The court looked to [2018] SGHC 123 regarding the impact of a representee's own business acumen on the issue of inducement.

The fourth issue was the existence of actionable loss. The plaintiff had to prove that it suffered a loss as a result of the misrepresentations. In the context of a share subscription, this typically requires proving that the price paid for the shares exceeded their actual value at the time of acquisition. The court had to decide if the plaintiff’s method of quantifying loss—based on the dividend shortfall—was a valid measure of damages in tort, or whether the failure to provide a professional valuation of the shares was fatal to the claim.

The final issue was the claim for unlawful means conspiracy. This required the plaintiff to prove a combination of two or more persons, an intention to injure the plaintiff, and the use of unlawful means (the misrepresentations) that caused damage. The court had to determine if there was a concerted plan between the defendants to defraud the plaintiff, applying the test from [2024] SGHC 177. This issue was inextricably linked to the success of the underlying misrepresentation claims.

How Did the Court Analyse the Issues?

The court began its analysis by addressing the fundamental question of whether the Alleged Representations were made. Mohamed Faizal JC noted that in cases involving oral representations in a commercial setting, the court must be "extremely cautious" (at [72]). The court applied the principle that where oral testimony is contradicted by the documentary matrix, the latter must prevail. The court found that the plaintiff's version of the meetings—specifically the claim that Mr. Bagri "guaranteed" a 9% dividend—was inherently improbable. The court observed that the Information Memorandum and the teasers explicitly used the term "target" and included standard disclaimers regarding future performance. It was commercially nonsensical for a sophisticated investor to believe that a fund manager would orally override these written terms with a flat guarantee of high returns in a private equity context.

Regarding the Dividend Rate Representation, the court scrutinized the email of 27 October 2016. While the plaintiff argued this email confirmed the 9% guarantee, the court found that it was equally consistent with the defendants' position that they were discussing a "target" yield. The court noted:

"I find that, on the balance of probabilities, the Alleged Representations were not made by the 2nd defendant in the manner suggested by the plaintiff." (at [72])

The court emphasized that if such a guarantee were truly the "deal-breaker" the plaintiff claimed it to be, it would have been recorded in the subscription agreement or at least in a confirmatory email from the plaintiff to the defendants. The absence of such documentation was a "telling omission" (at [84]).

The court then turned to the Calculation Methodology Representation. The plaintiff alleged that the 9% dividend was to be calculated on the "original" US$1.00 share price. The court found this claim to be logically flawed and unsupported by the evidence. The court noted that the plaintiff was paying ~US$2.80 per share; calculating a dividend on a historical price that the plaintiff did not pay would be an unusual and complex arrangement that would certainly have required written documentation. The court found that the plaintiff had likely misunderstood the "target yield" calculations presented in the marketing materials and was now attempting to re-characterize that misunderstanding as a misrepresentation by the defendants.

On the Ownership and Non-Disposal Representations, the court found that the plaintiff failed to prove these were material inducements. Even if Mr. Bagri had stated that Mr. Dash "owned" the shares, the court held that in a commercial context, "ownership" often refers to beneficial ownership through corporate entities. The plaintiff failed to show that it would have declined the investment had it known the shares were held by a Dash-controlled company rather than Mr. Dash personally. Regarding the non-disposal claim, the court found no evidence of a clear promise not to sell shares, noting that in private equity, the ability to exit positions is a standard feature of the business model.

The court’s analysis of Reliance and the Sophisticated Investor was particularly rigorous. Citing [2014] SGHC 8, the court noted that Mr. Choo was a "sophisticated investor" with significant experience. The court held that such an individual cannot easily claim to have been "induced" by oral statements that flatly contradict the written materials provided during due diligence. The court applied the "reasonable person" test in the context of the Misrepresentation Act 1967, finding that even if the statements were made, it was not reasonable for the plaintiff to rely on them without verifying them against the formal contract. The court also referenced [2018] SGHC 123, noting that the more sophisticated the representee, the more difficult it is to establish inducement by informal oral means.

A critical failure in the plaintiff's case was the Proof of Loss. The court held that the measure of damages for misrepresentation is the "out-of-pocket" rule—the difference between the price paid and the actual value of the asset at the time of acquisition. The plaintiff provided no expert valuation of the AVIVO shares as of November 2016. Instead, the plaintiff sought to recover the "dividend shortfall." The court rejected this, stating that tortious damages are not intended to put the plaintiff in the position they would have been in had the representation been true (the expectation measure), but rather the position they would have been in had the representation not been made. Without evidence that the shares were worth less than US$550,000 at the time of purchase, the plaintiff failed to prove any actionable damage. The court cited [2020] SGHC 219 and [2024] SGHC 103 to reinforce the necessity of proving actual loss in value.

Finally, the court dismissed the Unlawful Means Conspiracy claim. Since the plaintiff failed to prove the underlying "unlawful act" (the misrepresentations), the conspiracy claim had no foundation. The court noted that there was no evidence of an agreement between the three defendants to injure the plaintiff. The 3rd defendant, in particular, had minimal involvement in the specific communications alleged by the plaintiff. The court applied the elements from [2024] SGHC 177 and found that the plaintiff’s case fell far short of the required standard for proving a concerted plan to defraud.

What Was the Outcome?

The High Court dismissed the plaintiff's claims against all three defendants in their entirety. The court found that the plaintiff had failed to discharge its burden of proof regarding the making of the Alleged Representations, the reasonableness of any purported reliance, and the existence of actionable loss. The court's decision was a total rejection of the plaintiff's attempt to convert a disappointing investment outcome into a claim for fraud or negligence.

The operative paragraph of the judgment states:

"Consequently, I dismiss the suit in its entirety." (at [194])

Regarding the disposition per party:

  • Against the 1st Defendant (Regulus Advisors): The claims for fraudulent and negligent misrepresentation were dismissed because the court found the representations were not made, and even if they were, no loss was proven. The conspiracy claim failed for lack of an underlying unlawful act.
  • Against the 2nd Defendant (Amit Bagri): The claims were dismissed on the same grounds as the 1st defendant. The court specifically found Mr. Bagri’s testimony to be more consistent with the documentary evidence than Mr. Choo’s.
  • Against the 3rd Defendant (Don Lim): The claims were dismissed, with the court noting his limited involvement in the specific representations alleged.

On the matter of costs, the court did not make an immediate award but reserved the issue for further submissions. The judgment provided the following direction:

"If costs are not otherwise agreed, the parties are to file submissions on costs, limited to no more than ten pages each, within two weeks of the issuance of this judgment." (at [195])

The court's dismissal of the suit means that the plaintiff is likely to be ordered to pay the defendants' costs on a standard basis, subject to any specific arguments regarding the conduct of the litigation or any offers to settle that may have been made prior to trial. The judgment effectively brings an end to the plaintiff's attempt to recover the US$550,000 investment and the alleged dividend shortfall through the Singapore courts.

Why Does This Case Matter?

This case is a significant addition to Singapore's commercial jurisprudence, particularly regarding the protection of fund managers and investment advisors against claims of oral misrepresentation. It reinforces the "primacy of the written word" in sophisticated transactions. For practitioners, the judgment serves as a clear warning that the Singapore courts will not easily entertain allegations of oral guarantees that supplement or contradict formal investment documentation. The court’s reliance on the "inherent improbability" of such guarantees (at [72]) provides a powerful tool for defendants in similar cases, especially where the plaintiff is a sophisticated entity.

The decision also clarifies the "sophisticated investor" standard in the context of inducement and reliance. By emphasizing that a professional investor like Mr. Choo should have known better than to rely on oral assurances of "guaranteed" 9% returns, the court has raised the bar for such plaintiffs. This aligns with the broader judicial trend of expecting commercial parties to perform their own due diligence and to ensure that all critical terms are captured in the final contract. The court’s application of [2014] SGHC 8 and [2018] SGHC 123 demonstrates a consistent approach to holding sophisticated parties to the terms of their written agreements.

Furthermore, the judgment provides a masterclass in the evidentiary requirements for proving loss in misrepresentation claims. The court's rejection of the "dividend shortfall" as a measure of damages (at [141]) is a critical reminder that tortious damages are compensatory and backward-looking, not expectation-based. Practitioners must ensure they have robust expert valuation evidence to prove that an asset was worth less than the price paid at the time of the transaction. Without such evidence, even a proven misrepresentation may result in a "nominal" or zero-damage award, as seen here. This reinforces the principles in [2020] SGHC 219 and [2024] SGHC 103.

The dismissal of the unlawful means conspiracy claim also highlights the difficulty of proving a concerted plan to injure in a commercial setting. The court’s refusal to draw adverse inferences against the defendants for not calling certain witnesses, while scrutinizing the plaintiff's own failure to call corroborating witnesses, shows a balanced approach to the Evidence Act 1893. This case will be frequently cited by defense counsel seeking to strike out or dismiss claims based on alleged oral side-agreements in the private equity and fund management sectors. It reinforces Singapore's status as a jurisdiction that values contractual certainty and commercial reality over retrospective claims of oral misrepresentation.

Practice Pointers

  • Document All "Guarantees": Practitioners must advise clients that any "guaranteed" return or critical representation must be explicitly included in the written contract. Oral assurances, no matter how emphatic, are unlikely to be enforced if they contradict the written "target" language of the Information Memorandum.
  • Scrutinize "Target" Language: When defending fund managers, emphasize the distinction between "target" yields and "guaranteed" returns. The court in this case found the use of "target" in marketing materials to be a strong indicator that no guarantee was intended.
  • Sophistication as a Defense: Use the plaintiff's professional background and investment experience to challenge the reasonableness of their reliance on oral statements. The "sophisticated investor" standard is a potent shield against claims of inducement by informal means.
  • Valuation Evidence is Mandatory: In misrepresentation claims involving shares, do not rely on "loss of profit" or "dividend shortfall" as the measure of damages. You must provide a professional valuation of the shares at the time of acquisition to prove they were worth less than the price paid.
  • Contemporaneous Records Over Oral Testimony: In litigation, prioritize the discovery of internal emails, meeting notes, and draft agreements. The court will almost always prefer a "telling omission" in the documents over a witness's memory of a meeting from several years ago.
  • Be Wary of "Skin in the Game" Claims: Representations about a principal's personal ownership of shares should be verified. However, as this case shows, a court may view "ownership" through a corporate lens, making it difficult for a plaintiff to prove materiality or loss based on the specific entity holding the shares.
  • Address Exclusion Clauses Early: While the court did not need to rely on them here, ensure that subscription agreements contain robust "entire agreement" and "non-reliance" clauses to provide an additional layer of defense against claims of prior oral representations.

Subsequent Treatment

[None recorded in extracted metadata]

Legislation Referenced

Cases Cited

Source Documents

Written by Sushant Shukla
1.5×

More in

Legal Wires

Legal Wires

Stay ahead of the legal curve. Get expert analysis and regulatory updates natively delivered to your inbox.

Success! Please check your inbox and click the link to confirm your subscription.